Trial Site Detail

 

Drug:
Imatinib + Atezolizumab
Trial:
A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments (ATEZOGIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

ICANS Institut de Cancérologie Strasbourg

17 Rue Albert Calmette     
Strasbourg , 67200
France

 

Principal Investigator:
Justine GANTZER, MD
Contact:
03 68 76 72 25 j.gantzer@icans.eu
Activation Status of this Site:
Active
Notes about this Site:
ICANS Institut de Cancérologie Strasbourg Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.